XETRA - Delayed Quote EUR

Bayer Aktiengesellschaft (BAYN.DE)

50.58 +2.62 (+5.46%)

At close: 5:38:35 PM GMT+1

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Global Molecular Breeding Market Opportunities and Strategies to 2035 | Capitalize on Genomic Selection as Bayer, Syngenta, Corteva and BASF Drive a $21.55 Billion Market

GlobeNewswire 4h ago

BAYN.DE
+5.46%
CTVA

BAS.DE
Global Spray-Induced Gene Silencing (SIGS) Carrier Adjuvant Market Report 2026 | Capitalize on 9% CAGR Through 2030 as BASF, Bayer, Corteva and GreenLight Advance RNA Delivery

GlobeNewswire 4h ago

BAS.DE

BAYN.DE
+5.46%
CTVA
US jury hands win to Bayer in weedkiller cancer case

AFP 4h ago

BAYN.DE
+5.46%
Next-Generation Adeno-Associated Virus (AAV) Gene Therapy Delivery Market Report 2026 | Capitalize on $11.91B Market as Novartis, Voyager and Affinia Accelerate Engineered Capsids

GlobeNewswire 4h ago

NVS

PFE

BAYN.DE
+5.46%
Bayer Shares Rise After Win in First Roundup Trial Since Supreme Court Ruling

The Wall Street Journal 7h ago

BAYN.DE
+5.46%
BAYN
What BridgeBio Pharma (BBIO) Said on Its Q3 Earnings Call

MarketBeat 18h ago

BBIO

BAYN.DE
+5.46%
BridgeBio Reports Third Quarter 2026 Financial Results and Corporate Updates

GlobeNewswire 22h ago

BBIO

BAYN.DE
+5.46%
Market One Minute Feature on BNN Bloomberg: MustGrow Biologics and Bayer AG Discusses Validation of Its TerraMG Biocontrol Technology

TMX Newsfile 1d ago

MGRO.V

BAYN.DE
+5.46%
MGROF
Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards?

Zacks 1d ago

RXRX

SNY

ROP.SW
Orion Q3 operating profit beats forecasts as Nubeqa royalties jump

Investing.com 2d ago

BAYN.DE
+5.46%
ORNBV
Alurion Resources Quarterly Activities Report - September 2026

GlobeNewswire 2d ago

ALU.AX

BAYN.DE
+5.46%
Bayer Shares New Post Hoc Analysis Of Self-Reported Sleep-Related Outcomes with Lynkuet® (elinzanetant) in Women with Moderate to Severe Vasomotor Symptoms at the Menopause Society Annual Meeting

Business Wire 3d ago

BAYN.DE
+5.46%
BAYRY

Performance Overview

Return	BAYN.DE	DAX P (^GDAXI)
YTD	+37.06%	+5.42%
1-Year	+88.78%	+7.05%
3-Year	+25.80%	+75.44%

U.S. markets close in 1h 17m

Bayer Aktiengesellschaft (BAYN.DE)

Global Molecular Breeding Market Opportunities and Strategies to 2035 | Capitalize on Genomic Selection as Bayer, Syngenta, Corteva and BASF Drive a $21.55 Billion Market

Global Spray-Induced Gene Silencing (SIGS) Carrier Adjuvant Market Report 2026 | Capitalize on 9% CAGR Through 2030 as BASF, Bayer, Corteva and GreenLight Advance RNA Delivery

US jury hands win to Bayer in weedkiller cancer case

Next-Generation Adeno-Associated Virus (AAV) Gene Therapy Delivery Market Report 2026 | Capitalize on $11.91B Market as Novartis, Voyager and Affinia Accelerate Engineered Capsids

Bayer Shares Rise After Win in First Roundup Trial Since Supreme Court Ruling

What BridgeBio Pharma (BBIO) Said on Its Q3 Earnings Call

BridgeBio Reports Third Quarter 2026 Financial Results and Corporate Updates

Market One Minute Feature on BNN Bloomberg: MustGrow Biologics and Bayer AG Discusses Validation of Its TerraMG Biocontrol Technology

Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards?

Orion Q3 operating profit beats forecasts as Nubeqa royalties jump

Alurion Resources Quarterly Activities Report - September 2026

Bayer Shares New Post Hoc Analysis Of Self-Reported Sleep-Related Outcomes with Lynkuet® (elinzanetant) in Women with Moderate to Severe Vasomotor Symptoms at the Menopause Society Annual Meeting